Brigitte T. Huber - Publications

Affiliations: 
Cellular & Molecular Physiology Sackler School of Graduate Biomedical Sciences (Tufts University) 
Area:
Cell Biology, Molecular Biology

109 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Weindel CG, Richey LJ, Mehta AJ, Shah M, Huber BT. Autophagy in Dendritic Cells and B Cells Is Critical for the Inflammatory State of TLR7-Mediated Autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 28031336 DOI: 10.4049/Jimmunol.1601307  0.376
2015 Weindel CG, Richey LJ, Bolland S, Mehta AJ, Kearney JF, Huber BT. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy. 11: 1010-24. PMID 26120731 DOI: 10.1080/15548627.2015.1052206  0.383
2014 Vu DM, Tai A, Tatro JB, Karas RH, Huber BT, Beasley D. γδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice. Plos One. 9: e109416. PMID 25313857 DOI: 10.1371/Journal.Pone.0109416  0.375
2011 Mele DA, Sampson JF, Huber BT. Th17 differentiation is the default program for DPP2-deficient T-cell differentiation. European Journal of Immunology. 41: 1583-93. PMID 21469121 DOI: 10.1002/Eji.201041157  0.772
2011 Moriyama M, Fukuhara T, Britschgi M, He Y, Narasimhan R, Villeda S, Molina H, Huber BT, Holers M, Wyss-Coray T. Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 3981-9. PMID 21411641 DOI: 10.1523/Jneurosci.3617-10.2011  0.339
2011 Kulik L, Chen K, Huber BT, Holers VM. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists. Molecular Immunology. 48: 883-94. PMID 21269698 DOI: 10.1016/J.Molimm.2010.12.019  0.393
2010 Danilov AV, Danilova OV, Brown JR, Rabinowitz A, Klein AK, Huber BT. Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia. Experimental Hematology. 38: 1167-77. PMID 20817072 DOI: 10.1016/J.Exphem.2010.08.008  0.36
2009 Danilova OV, Tai AK, Mele DA, Beinborn M, Leiter AB, Greenberg AS, Perfield JW, Defuria J, Singru PS, Lechan RM, Huber BT. Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity. Endocrinology. 150: 5240-8. PMID 19819973 DOI: 10.1210/En.2009-0386  0.71
2009 Mele DA, Bista P, Baez DV, Huber BT. Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescence. Cell Cycle (Georgetown, Tex.). 8: 2425-34. PMID 19556882 DOI: 10.4161/Cc.8.15.9144  0.739
2009 Tai AK, Luka J, Ablashi D, Huber BT. HHV-6A infection induces expression of HERV-K18-encoded superantigen. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 46: 47-8. PMID 19505843 DOI: 10.1016/J.Jcv.2009.05.019  0.369
2009 Marko MG, Pang HJ, Ren Z, Azzi A, Huber BT, Bunnell SC, Meydani SN. Vitamin E reverses impaired linker for activation of T cells activation in T cells from aged C57BL/6 mice. The Journal of Nutrition. 139: 1192-7. PMID 19403707 DOI: 10.3945/Jn.108.103416  0.399
2009 Hsiao FC, Tai AK, Deglon A, Sutkowski N, Longnecker R, Huber BT. EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology. 385: 261-6. PMID 19070345 DOI: 10.1016/J.Virol.2008.11.025  0.731
2009 Danilov AV, Danilova O, Klein A, Brown J, Rabinowitz AP, Miller KB, Huber BT. ZAP-70 Disrupts Dipeptidyl Peptidase 2 (DPP2)-Regulated Quiescence in Chronic Lymphocytic Leukemia (CLL). Blood. 114: 1251-1251. DOI: 10.1182/Blood.V114.22.1251.1251  0.4
2008 Bista P, Mele DA, Baez DV, Huber BT. Lymphocyte quiescence factor Dpp2 is transcriptionally activated by KLF2 and TOB1. Molecular Immunology. 45: 3618-23. PMID 18555530 DOI: 10.1016/J.Molimm.2008.05.001  0.747
2008 Kulik L, Hannan JP, Huber BT, Holers VM. Treatment with a highly inhibitory monoclonal antibody directed to the C3d ligand binding site on human CR2/CD21 suppresses antigen-specific immune responses in vivo Molecular Immunology. 45: 4111-4112. DOI: 10.1016/J.Molimm.2008.08.050  0.3
2007 Iliopoulou BP, Alroy J, Huber BT. CD28 deficiency exacerbates joint inflammation upon Borrelia burgdorferi infection, resulting in the development of chronic Lyme arthritis. Journal of Immunology (Baltimore, Md. : 1950). 179: 8076-82. PMID 18056348 DOI: 10.4049/Jimmunol.179.12.8076  0.314
2007 Ghosh S, Huber BT. Clonal diversification in OspA-specific antibodies from peripheral circulation of a chronic Lyme arthritis patient. Journal of Immunological Methods. 321: 121-34. PMID 17307198 DOI: 10.1016/J.Jim.2007.01.007  0.348
2007 Chen G, Tai AK, Lin M, Chang F, Terhorst C, Huber BT. Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death. European Journal of Immunology. 37: 663-74. PMID 17266174 DOI: 10.1002/Eji.200636417  0.472
2007 Marko MG, Ahmed T, Bunnell SC, Wu D, Chung H, Huber BT, Meydani SN. Age-associated decline in effective immune synapse formation of CD4(+) T cells is reversed by vitamin E supplementation. Journal of Immunology (Baltimore, Md. : 1950). 178: 1443-9. PMID 17237392 DOI: 10.4049/Jimmunol.178.3.1443  0.422
2007 Danilov AV, Danilova OV, Klein AK, Huber BT. Apoptosis in Response to Inhibition of Dipeptidyl Peptidase 2 (DPP2) Defines Low Risk Chronic Lymphocytic Leukemia (CLL). Blood. 110: 3094-3094. DOI: 10.1182/Blood.V110.11.3094.3094  0.382
2006 Danilov AV, Danilova OV, Klein AK, Huber BT. Molecular pathogenesis of chronic lymphocytic leukemia. Current Molecular Medicine. 6: 665-75. PMID 17022736 DOI: 10.2174/156652406778195008  0.43
2006 Tai AK, Lin M, Chang F, Chen G, Hsiao F, Sutkowski N, Huber BT. Murine Vbeta3+ and Vbeta7+ T cell subsets are specific targets for the HERV-K18 Env superantigen. Journal of Immunology (Baltimore, Md. : 1950). 177: 3178-84. PMID 16920956 DOI: 10.4049/Jimmunol.177.5.3178  0.767
2006 Hsiao FC, Lin M, Tai A, Chen G, Huber BT. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 2056-60. PMID 16887963 DOI: 10.4049/Jimmunol.177.4.2056  0.758
2006 Crowley H, Alroy J, Sproule TJ, Roopenian D, Huber BT. The MHC class I-related FcRn ameliorates murine Lyme arthritis. International Immunology. 18: 409-14. PMID 16415101 DOI: 10.1093/Intimm/Dxh380  0.343
2006 Danilov AV, Danilova OV, Klein AK, Huber BT. Dipeptidyl Peptidase 2 - A Pro-Survival Molecule in Chronic Lymphocytic Leukemia. Blood. 108: 4964-4964. DOI: 10.1182/Blood.V108.11.4964.4964  0.402
2005 Guerau-de-Arellano M, Alroy J, Bullard D, Huber BT. Aggravated Lyme carditis in CD11a-/- and CD11c-/- mice. Infection and Immunity. 73: 7637-43. PMID 16239568 DOI: 10.1128/Iai.73.11.7637-7643.2005  0.348
2005 Chen G, Tai AK, Lin M, Chang F, Terhorst C, Huber BT. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. Journal of Immunology (Baltimore, Md. : 1950). 175: 2212-8. PMID 16081788 DOI: 10.4049/Jimmunol.175.4.2212  0.445
2005 Guerau-de-Arellano M, Alroy J, Huber BT. Beta2 integrins control the severity of murine Lyme carditis. Infection and Immunity. 73: 3242-50. PMID 15908348 DOI: 10.1128/Iai.73.6.3242-3250.2005  0.36
2005 Ausubel LJ, O'Connor KC, Baecher-Allen C, Trollmo C, Kessler B, Hekking B, Merritt D, Meyer AL, Kwok B, Ploegh H, Huber BT, Hafler DA. Characterization of in vivo expanded OspA-specific human T-cell clones. Clinical Immunology (Orlando, Fla.). 115: 313-22. PMID 15893699 DOI: 10.1016/J.Clim.2005.02.015  0.433
2005 Morra M, Barrington RA, Abadia-Molina AC, Okamoto S, Julien A, Gullo C, Kalsy A, Edwards MJ, Chen G, Spolski R, Leonard WJ, Huber BT, Borrow P, Biron CA, Satoskar AR, et al. Defective B cell responses in the absence of SH2D1A. Proceedings of the National Academy of Sciences of the United States of America. 102: 4819-23. PMID 15774582 DOI: 10.1073/Pnas.0408681102  0.453
2005 Ghosh S, Steere AC, Stollar BD, Huber BT. In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium. Journal of Immunology (Baltimore, Md. : 1950). 174: 2860-9. PMID 15728496 DOI: 10.4049/Jimmunol.174.5.2860  0.372
2005 Danilov AV, Klein AK, Lee HJ, Baez DV, Huber BT. Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor. British Journal of Haematology. 128: 472-81. PMID 15686454 DOI: 10.1111/J.1365-2141.2004.05346.X  0.408
2004 Ahmed T, Marko M, Wu D, Chung H, Huber B, Meydani SN. Vitamin E supplementation reverses the age-associated decrease in effective immune synapse formation in CD4+ T cells. Annals of the New York Academy of Sciences. 1031: 412-4. PMID 15753183 DOI: 10.1196/Annals.1331.059  0.414
2004 Sutkowski N, Chen G, Calderon G, Huber BT. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. Journal of Virology. 78: 7852-60. PMID 15220463 DOI: 10.1128/Jvi.78.14.7852-7860.2004  0.416
2004 Willett TA, Meyer AL, Brown EL, Huber BT. An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proceedings of the National Academy of Sciences of the United States of America. 101: 1303-8. PMID 14742868 DOI: 10.1073/Pnas.0305680101  0.371
2003 Crowley H, Huber BT. Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infection and Immunity. 71: 4003-10. PMID 12819088 DOI: 10.1128/Iai.71.7.4003-4010.2003  0.347
2003 Li W, Rosenzweig A, Huber BT. Differential T-cell activation by B7-1 expression. Immunology. 109: 336-42. PMID 12807478 DOI: 10.1046/J.1365-2567.2003.01658.X  0.469
2003 Seward RJ, von Haller PD, Aebersold R, Huber BT. Phosphorylation of the pro-apoptotic protein Bim in lymphocytes is associated with protection from apoptosis. Molecular Immunology. 39: 983-93. PMID 12749905 DOI: 10.1016/S0161-5890(03)00047-6  0.327
2003 Sutkowski N, Huber BT. Assessment of specific T-cell activation by superantigens. Methods in Molecular Biology (Clifton, N.J.). 214: 185-217. PMID 12489463 DOI: 10.1385/1-59259-367-4:185  0.401
2002 Guerau-de-Arellano M, Huber BT. Development of autoimmunity in Lyme arthritis. Current Opinion in Rheumatology. 14: 388-93. PMID 12118172 DOI: 10.1097/00002281-200207000-00009  0.338
2001 Stauffer Y, Marguerat S, Meylan F, Ucla C, Sutkowski N, Huber B, Pelet T, Conrad B. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. Immunity. 15: 591-601. PMID 11672541 DOI: 10.1016/S1074-7613(01)00212-6  0.374
2001 Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 15: 579-89. PMID 11672540 DOI: 10.1016/S1074-7613(01)00210-2  0.488
2001 Adolfsson O, Huber BT, Meydani SN. Vitamin E-enhanced IL-2 production in old mice: Naive but not memory T cells show increased cell division cycling and IL-2-producing capacity Journal of Immunology. 167: 3809-3817. PMID 11564798 DOI: 10.4049/Jimmunol.167.7.3809  0.415
2001 Chen J, Huber BT, Grand RJ, Li W. Recombinant adenovirus coexpressing covalent peptide/MHC class II complex and B7-1: in vitro and in vivo activation of myelin basic protein-specific T cells. Journal of Immunology (Baltimore, Md. : 1950). 167: 1297-305. PMID 11466346 DOI: 10.4049/Jimmunol.167.3.1297  0.422
2001 Steere AC, Gross D, Meyer AL, Huber BT. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis Journal of Autoimmunity. 16: 263-268. PMID 11334491 DOI: 10.1006/Jaut.2000.0495  0.317
2001 Trollmo C, Meyer AL, Steere AC, Hafler DA, Huber BT. Molecular mimicry in lyme arthritis demonstrated at the single cell level: LFA-1αL is a partial agonist for outer surface protein A-reactive T cells Journal of Immunology. 166: 5286-5291. PMID 11290815 DOI: 10.4049/Jimmunol.166.8.5286  0.438
2001 Chiravuri M, Huber BT. Aminodipeptidase inhibitor-induced cell death in quiescent lymphocytes: a review. Apoptosis : An International Journal On Programmed Cell Death. 5: 319-22. PMID 11227212 DOI: 10.1023/A:1009675223443  0.356
2000 Gross DM, Huber BT. Cellular and molecular aspects of Lyme arthritis. Cellular and Molecular Life Sciences : Cmls. 57: 1562-9. PMID 11092451 DOI: 10.1007/Pl00000641  0.326
2000 Chiravuri M, Agarraberes F, Mathieu SL, Lee H, Huber BT. Vesicular localization and characterization of a novel post-proline-cleaving aminodipeptidase, quiescent cell proline dipeptidase. Journal of Immunology (Baltimore, Md. : 1950). 165: 5695-702. PMID 11067927 DOI: 10.4049/Jimmunol.165.10.5695  0.348
2000 Meyer AL, Trollmo C, Crawford F, Marrack P, Steere AC, Huber BT, Kappler J, Hafler DA. Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proceedings of the National Academy of Sciences of the United States of America. 97: 11433-8. PMID 11005833 DOI: 10.1073/Pnas.190335897  0.434
2000 Xu L, Tay CH, Huber BT, Sarkar NH. Cloning of an infectious milk-borne mouse mammary tumor virus (MMTV) DNA from a mammary tumor that developed in an endogenous MMTV-free wild mouse. Virology. 273: 325-32. PMID 10915603 DOI: 10.1006/Viro.2000.0437  0.323
2000 Chiravuri M, Lee H, Mathieu SL, Huber BT. Homodimerization via a leucine zipper motif is required for enzymatic activity of quiescent cell proline dipeptidase. The Journal of Biological Chemistry. 275: 26994-9. PMID 10867015 DOI: 10.1074/Jbc.M005445200  0.318
1999 Klempner MS, Huber BT. Is it thee or me?--autoimmunity in Lyme disease. Nature Medicine. 5: 1346-7. PMID 10581067 DOI: 10.1038/70907  0.35
1999 Underwood R, Chiravuri M, Lee H, Schmitz T, Kabcenell AK, Yardley K, Huber BT. Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. The Journal of Biological Chemistry. 274: 34053-8. PMID 10567372 DOI: 10.1074/Jbc.274.48.34053  0.326
1999 Chen J, Field JA, Glickstein L, Molloy PJ, Huber BT, Steere AC. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis and Rheumatism. 42: 1813-22. PMID 10513794 DOI: 10.1002/1529-0131(199909)42:9<1813::Aid-Anr4>3.0.Co;2-0  0.361
1998 Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (New York, N.Y.). 281: 703-6. PMID 9685265 DOI: 10.1126/Science.281.5377.703  0.335
1998 Xie H, Seward RJ, Huber BT. Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of IkappaBalpha. Molecular Immunology. 34: 987-94. PMID 9488049 DOI: 10.1016/S0161-5890(97)00128-4  0.39
1997 Arroyo J, Winchester E, McLellan BS, Huber BT. Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain. Journal of Virology. 71: 1237-45. PMID 8995647 DOI: 10.1128/Jvi.71.2.1237-1245.1997  0.412
1996 Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen Journal of Experimental Medicine. 184: 971-980. PMID 9064357 DOI: 10.1084/Jem.184.3.971  0.486
1996 Beutner U, McLellan B, Kraus E, Huber BT. Lack of MMTV superantigen presentation in MHC class II-deficient mice. Cellular Immunology. 168: 141-7. PMID 8640859 DOI: 10.1006/Cimm.1996.0060  0.396
1996 Schmitz T, Underwood R, Khiroya R, Bachovchin WW, Huber BT. Potentiation of the immune response in HIV-1+ individuals Journal of Clinical Investigation. 97: 1545-1549. PMID 8617888 DOI: 10.1172/Jci118577  0.322
1996 Huber BT. The role of superantigens in virus infection. Journal of Clinical Immunology. 15: 22S-25S. PMID 8613488 DOI: 10.1007/Bf01540890  0.429
1996 Huber BT, Hsu PN, Sutkowski N. Virus-encoded superantigens. Microbiological Reviews. 60: 473-482. DOI: 10.1128/Mmbr.60.3.473-482.1996  0.32
1995 Mottershead DG, Hsu PN, Urban RG, Strominger JL, Huber BT. Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity. 2: 149-54. PMID 7895171 DOI: 10.1016/S1074-7613(95)80027-1  0.343
1995 Huber BT, Beutner U, Subramanyam M. The role of superantigens in the immunobiology of retroviruses. Ciba Foundation Symposium. 187: 132-40; discussion 1. PMID 7796668 DOI: 10.1002/9780470514672.ch9  0.396
1994 Chambers CA, Kang J, Pawling J, Huber B, Hozumi N, Nagy A. Exogenous Mtv-7 superantigen transgene expression in major histocompatibility complex class II I-E- mice reconstituted with embryonic stem cell-derived hematopoietic stem cells Proceedings of the National Academy of Sciences of the United States of America. 91: 1138-1142. PMID 8302843 DOI: 10.1073/Pnas.91.3.1138  0.427
1994 Beutner U, Kraus E, Kitamura D, Rajewsky K, Huber BT. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. The Journal of Experimental Medicine. 179: 1457-66. PMID 8163931 DOI: 10.1084/Jem.179.5.1457  0.461
1994 Thibodeau J, Labrecque N, Denis F, Huber BT, Sékaly RP. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules Journal of Experimental Medicine. 179: 1029-1034. PMID 8113671 DOI: 10.1084/Jem.179.3.1029  0.344
1994 Gutheil WG, Subramanyam M, Flentke GR, Sanford DG, Munoz E, Huber BT, Bachovchin WW. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proceedings of the National Academy of Sciences of the United States of America. 91: 6594-8. PMID 7912830 DOI: 10.1073/Pnas.91.14.6594  0.431
1993 Labrecque N, McGrath H, Subramanyam M, Huber BT, Sekaly RP. Human T cells respond to mouse mammary tumor virus-encoded superantigen: Vβ restriction and conserved evolutionary features Journal of Experimental Medicine. 177: 1735-1743. PMID 8388432 DOI: 10.1084/Jem.177.6.1735  0.451
1993 Mohan N, Mottershead D, Subramanyam M, Beutner U, Huber BT. Production and characterization of an Mls-1-specific monoclonal antibody. The Journal of Experimental Medicine. 177: 351-8. PMID 8381154 DOI: 10.1084/Jem.177.2.351  0.452
1992 Huber BT. Mls genes and self-superantigens. Trends in Genetics : Tig. 8: 399-402. PMID 1332231 DOI: 10.1016/0168-9525(92)90302-K  0.385
1992 Muñoz E, Zubiaga AM, Huber BT. Interleukin-1 induces c-fos and c-jun gene expression in T helper type II cells through different signal transmission pathways. European Journal of Immunology. 22: 2101-6. PMID 1322303 DOI: 10.1002/Eji.1830220821  0.305
1992 Beutner U, Frankel WN, Cote MS, Coffin JM, Huber BT. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proceedings of the National Academy of Sciences of the United States of America. 89: 5432-6. PMID 1319061 DOI: 10.1073/Pnas.89.12.5432  0.35
1992 Beutner U, Rudy C, Huber BT. Molecular characterization of Mls-1. International Reviews of Immunology. 8: 279-88. PMID 1318934 DOI: 10.3109/08830189209053513  0.375
1992 Rudy CK, Kraus E, Palmer E, Huber BT. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7. The Journal of Experimental Medicine. 175: 1613-21. PMID 1316931 DOI: 10.1084/Jem.175.6.1613  0.372
1991 Muñoz E, Zubiaga AM, Muñoz J, Huber BT. Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells. Cell Regulation. 1: 425-34. PMID 1983070 DOI: 10.1091/Mbc.1.5.425  0.42
1991 Merrow MW, Huber BT. rIL-4 differentially regulates rIL-2-induced murine NK and LAK killing in CD8+ and CD8- precursor cell subsets. International Immunology. 3: 551-61. PMID 1909562 DOI: 10.1093/Intimm/3.6.551  0.334
1991 Molina IJ, Huber BT. Regulation of macrophage activation markers by IL-4 and IFN-γ is subpopulation-specific Cellular Immunology. 134: 241-248. PMID 1901520 DOI: 10.1016/0008-8749(91)90347-E  0.363
1991 Frankel WN, Rudy C, Coffin JM, Huber BT. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice Nature. 349: 526-528. PMID 1846948 DOI: 10.1038/349526A0  0.408
1991 Muñoz E, Zubiaga AM, Huber BT. Tyrosine protein phosphorylation is required for protein kinase C-mediated proliferation in T cells. Febs Letters. 279: 319-22. PMID 1705899 DOI: 10.1016/0014-5793(91)80178-6  0.349
1991 Flentke GR, Munoz E, Huber BT, Plaut AG, Kettner CA, Bachovchin WW. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function Proceedings of the National Academy of Sciences of the United States of America. 88: 1556-1559. PMID 1671716 DOI: 10.1073/Pnas.88.4.1556  0.441
1990 Muñoz E, Zubiaga A, Olson D, Huber BT. Control of lymphokine expression in T helper 2 cells. Proceedings of the National Academy of Sciences of the United States of America. 86: 9461-4. PMID 2531899 DOI: 10.1073/Pnas.86.23.9461  0.381
1990 Muñoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. The Journal of Experimental Medicine. 172: 95-103. PMID 2162906 DOI: 10.1084/Jem.172.1.95  0.398
1990 Zubiaga AM, Munoz E, Merrow M, Huber BT. Regulation of interleukin 6 production in T helper cells. International Immunology. 2: 1047-54. PMID 1964588 DOI: 10.1093/Intimm/2.11.1047  0.405
1988 Payne J, Huber BT, Cannon NA, Schneider R, Schilham MW, Acha-Orbea H, MacDonald HR, Hengartner H. Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptor. Proceedings of the National Academy of Sciences of the United States of America. 85: 7695-8. PMID 2459713 DOI: 10.1073/Pnas.85.20.7695  0.381
1987 Sherman DH, Hochman PS, Dick R, Tizard R, Ramachandran KL, Flavell RA, Huber BT. Molecular analysis of antigen recognition by insulin-specific T-cell hybridomas from B6 wild-type and bm12 mutant mice. Molecular and Cellular Biology. 7: 1865-72. PMID 2439899 DOI: 10.1128/Mcb.7.5.1865  0.429
1985 Hochman PS, Huber BT. A class II gene conversion event defines an antigen-specific Ir gene epitope. The Journal of Experimental Medicine. 160: 1925-30. PMID 6210340 DOI: 10.1084/Jem.160.6.1925  0.359
1985 Huber BT, Hochman PS. B cell activation potential of insulin-reactive T cells in H-2b mice. European Journal of Immunology. 14: 1106-10. PMID 6083870 DOI: 10.1002/Eji.1830141208  0.428
1984 Hochman PS, Huber BT. Immune recognition of insulin by H-2b mice: the mutation in the I-Ab beta gene of the B6.C-H-2bm12 mouse alters the self-I-A-restricted T cell repertoire. European Journal of Immunology. 14: 610-5. PMID 6204877 DOI: 10.1002/Eji.1830140706  0.359
1983 Nakajima PB, Huber BT. Functional evidence for abnormal maturation within a B-cell subpopulation of NZB mice. Cellular Immunology. 71: 270-81. PMID 6982766 DOI: 10.1016/0008-8749(82)90261-1  0.398
1983 Kemp JD, Rohrer JW, Huber BT. Lyb3: a B cell surface antigen associated with triggering secretory differentiation. Immunological Reviews. 69: 127-40. PMID 6218069 DOI: 10.1111/J.1600-065X.1983.Tb00452.X  0.428
1982 Letvin NL, Huber BT, Benacerraf B. B-lymphocyte responses to trinitrophenyl-ficoll. II. Decreased splenic adherent cell function in mice expressing the xid gene. Cellular Immunology. 70: 241-7. PMID 6982103 DOI: 10.1016/0008-8749(82)90325-2  0.388
1982 Huber BT. B cell differentiation antigens as probes for functional B cell subsets. Immunological Reviews. 64: 57-79. PMID 6806173 DOI: 10.1111/J.1600-065X.1982.Tb00418.X  0.388
1982 Huber BT, Rosenwasser LJ. Role of Ia. W39 in the interaction of antigen-presenting cells with T and B lymphocytes. European Journal of Immunology. 12: 37-43. PMID 6460640 DOI: 10.1002/Eji.1830120109  0.44
1981 Huber BT, Tokuhisa T, Herzenberg LA. Primary and secondary in situ antibody response: abnormal affinity maturation pattern in mice carrying the xid gene. European Journal of Immunology. 11: 353-7. PMID 6973472 DOI: 10.1002/Eji.1830110502  0.334
1981 Huber BT, Jones PP, Thorley-Lawson D. Structural analysis of a new B-cell-differentiation antigen associated with products of the I-A subregion of the H-2 complex. Proceedings of the National Academy of Sciences of the United States of America. 78: 4525-9. PMID 6794033 DOI: 10.1073/Pnas.78.7.4525  0.344
1981 Rosenwasser LJ, Huber BT. The xid gene controls Ia.W39-associated immune response gene function. The Journal of Experimental Medicine. 153: 1113-23. PMID 6788886 DOI: 10.1084/Jem.153.5.1113  0.333
1981 Sherr DH, Huber BT, Gershon RK, Benacerraf B, Dorf ME. Effect of anti-Lyb3 antiserum on poly (L-glutamic acid, L-lysine)-induced B cell tolerance. European Journal of Immunology. 11: 241-6. PMID 6165589 DOI: 10.1002/Eji.1830110314  0.384
1980 Kemp J, Dohrman L, Jayawardena A, Huber B, Gershon RK. B-cell subsets in autoimmunity: An autoimmune hemolytic response to mouse erythrocytes is modulated by the CBA/N defect and Anti-Lyb3 antisera Cellular Immunology. 53: 84-93. PMID 6967764 DOI: 10.1016/0008-8749(80)90428-1  0.435
1980 Nakajima PB, Datta SK, Schwartz RS, Huber BT. Localization of spontaneously hyperactive B cells of NZB mice to a specific B cell subset. Proceedings of the National Academy of Sciences of the United States of America. 76: 4613-6. PMID 315562 DOI: 10.1073/Pnas.76.9.4613  0.374
1979 Huber B, Melchers F. Frequencies of mitogen-reactive B cells in the mouse. Lipopolysaccharide-, lipoprotein- and Nocardia mitogen-reactive B cells in CBA/N mice European Journal of Immunology. 9: 827-829. PMID 316394 DOI: 10.1002/Eji.1830091016  0.369
1979 Sousa Md, Freitas A, Huber B, Cantor H, Boyse EA. MIGRATORY PATTERNS OF THE Ly SUBSETS OF T LYMPHOCYTES IN THE MOUSE Advances in Experimental Medicine and Biology. 114: 51-54. PMID 313679 DOI: 10.1007/978-1-4615-9101-6_8  0.429
1979 Huber BT. Antigenic marker on a functional subpopulation of B cells, controlled by the I-A subregion of the H-2 complex. Proceedings of the National Academy of Sciences of the United States of America. 76: 3460-3. PMID 91165 DOI: 10.1073/Pnas.76.7.3460  0.385
1977 Huber B, Gershon RK, Cantor H. Identification of a B-cell surface structure involved in antigen-dependent triggering: absence of this structure on B cells from CBA/N mutant mice. The Journal of Experimental Medicine. 145: 10-20. PMID 299766 DOI: 10.1084/Jem.145.1.10  0.43
1976 Huber B, Devinsky O, Gershon RK, Cantor H. Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses. The Journal of Experimental Medicine. 143: 1534-9. PMID 1083891 DOI: 10.1084/Jem.143.6.1534  0.429
1976 Huber B, Cantor H, Shen FW, Boyse EA. Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses. The Journal of Experimental Medicine. 144: 1128-33. PMID 62012 DOI: 10.1084/Jem.144.4.1128  0.444
1975 Festenstein H, Huber B, Abbasi K, Tuffrey M, Gardner R, Barnes RD. INVESTIGATIONS OF IMMUNOLOGICAL TOLERANCE IN TETRAPARENTAL MOUSE CHIMAERAS European Journal of Immunogenetics. 2: 351-363. DOI: 10.1111/J.1744-313X.1975.Tb00544.X  0.31
1975 Festenstein H, Huber B, Keeling V, Demant P. The genetic basis of antigenic strength in heart and skin allografting Journal of Immunogenetics. 2: 309-316. DOI: 10.1111/J.1744-313X.1975.Tb00540.X  0.336
Show low-probability matches.